Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is O  [Clear All Filters]
Hsu, J., Chen, Z., Shore, T., Gergis, U., Mayer, S., Phillips, A., Guarner, D., Hsu, M., Cushing, M.M., and van Besien, K. (2019). OUTCOMES OF ALLOGENEIC STEM CELL TRANSPLANT FOR ELDERLY PATIENTS WITH HEMATOLOGIC MALIGNANCIES.Biol Blood Marrow Transplant.
Marks, D.I., Kebriaei, P., Stelljes, M., Gökbuget, N., Kantarjian, H., Advani, A.S., Merchant, A., Stock, W., Cassaday, R.D., Wang, T., et al. (2019). Outcomes of allogeneic stem cell transplantation after inotuzumab ozogamicin treatment for relapsed or refractory acute lymphoblastic leukemia.Biol Blood Marrow Transplant.
Sanders, S., Chua, N., Larouche, J.-F., Owen, C., Shafey, M., and Stewart, D.A. (2019). Outcomes of Consecutively Diagnosed Primary Central Nervous System Lymphoma Patients Using the Alberta Lymphoma Clinical Practice Guideline Incorporating Thiotepa-Busulfan Conditioning for Transplant-Eligible Patients.Biol Blood Marrow Transplant.
Shah, G., Mikhail, F.M., Bachiasvilli, K., Vachhani, P., Erba, H.P., and Papadantonakis, N. (2019). Outcomes of high-risk acute promyelocytic leukemia patients treated with arsenic trioxide (ATO)/all trans retinoic acid (ATRA) based induction and consolidation without maintenance phase.Hematol Oncol Stem Cell Ther.
Halder, R., Mishra, P., Dhawan, R., Aggarwal, M., Seth, T., Mahapatra, M., and Saxena, R. (2019). Outcomes of paroxysmal nocturnal hemoglobinuria in the pediatric age group in a resource-constrained setting.Pediatr Blood Cancere27712.
Wali, R., Saeed, H., Patrus, N., Javed, S., and Khan, S.Javed (2019). Outcomes of Refractory and Relapsed Hodgkin Lymphoma With Autologous Stem-Cell Transplantation: A Single Institution Experience.J Glob Oncol5, 1-6.
Malenda, A., Kołkowska-Leśniak, A., Puła, B., Długosz-Danecka, M., Chełstowska, M., Końska, A., Giza, A., Lech-Maranda, E., Jurczak, W., and Warzocha, K. (2019). Outcomes of treatment with dose-adjusted EPOCH-R or R-CHOP in primary mediastinal large B-cell lymphoma.Eur J Haematol.
Lammert, J., Skandarajah, A.R., Shackleton, K., Calder, P., Thomas, S., Lindeman, G.J., and Mann, G.Bruce (2019). Outcomes of women at high familial risk for breast cancer: An 8-year single-center experience.Asia Pac J Clin Oncol.
Hatina, J., Boesch, M., Sopper, S., Kripnerova, M., Wolf, D., Reimer, D., Marth, C., and Zeimet, A.G. (2019). Ovarian Cancer Stem Cell Heterogeneity.Adv Exp Med Biol1139, 201-221.
Su, Y.-K., Bamodu, O.Adebayo, Tzeng, Y.-M., Hsiao, M., Yeh, C.-T., and Lin, C.-M. (2019). Ovatodiolide inhibits the oncogenicity and cancer stem cell-like phenotype of glioblastoma cells, as well as potentiate the anticancer effect of temozolomide.Phytomedicine61, 152840.
Xiang, J., Ding, Y., Li, J., Zhao, X., Sun, Y., Wang, D., Wang, L., and Chen, Y. (2019). Ovatodiolides: Scalable Protection-free Syntheses, Configuration Determination and Biological Evaluation against Hepatic Cancer Stem Cells.Angew Chem Int Ed Engl.
Kawai, H., Matsushita, H., Suzuki, R., Kitamura, Y., Ogawa, Y., Kawada, H., and Ando, K. (2019). Overcoming Tyrosine Kinase Inhibitor Resistance in Transformed Cell Harboring SEPT9-ABL1 Chimeric Fusion Protein.Neoplasia21, 788-801.
Yu, K., Wang, J., Lu, T., Ma, D., Wei, D., Guo, Y., Cheng, B., Wang, W., and Fang, Q. (2019). Overexpression of heme oxygenase-1 in microenvironment mediates vincristine resistance of B-cell acute lymphoblastic leukemia by promoting vascular endothelial growth factor secretion.J Cell Biochem.
Yu, Y., Li, M., Song, Y., Xu, J., and Qi, F. (2019). Overexpression of long noncoding RNA CUDR promotes hepatic differentiation of human umbilical cord mesenchymal stem cells.Mol Med Rep.
Hu, Y., Song, Z., Chen, J., and Caulin, C. (2019). Overexpression of MYB in the skin induces alopecia and epidermal hyperplasia.J Invest Dermatol.
Lu, C., Shi, X., Allen, A., Baez-Nieto, D., Nikish, A., Sanjana, N.E., and Pan, J.Q. (2019). Overexpression of NEUROG2 and NEUROG1 in human embryonic stem cells produces a network of excitatory and inhibitory neurons.Faseb Jfj201801110RR.
Ni, L., Yu, J., Gui, X., Lu, Z., Wang, X., Guo, H., and Zhou, Y. (2019). Overexpression of RPN2 promotes osteogenic differentiation of hBMSCs through the JAK/STAT3 pathway.Febs Open Bio.
Trostchansky, A. (2019). Overview of Lipid Biomarkers in Amyotrophic Lateral Sclerosis (ALS).Adv Exp Med Biol1161, 233-241.
Wu, H.Fu, and Zeltner, N. (2019). Overview of Methods to Differentiate Sympathetic Neurons from Human Pluripotent Stem Cells.Curr Protoc Stem Cell Biol50, e92.
Stojanovska, V., Prakash, M., McQuade, R., Fraser, S., Apostolopoulos, V., Sakkal, S., and Nurgali, K. (2019). Oxaliplatin Treatment Alters Systemic Immune Responses.Biomed Res Int2019, 4650695.
Perikamana, S.Kumar Madh, Lee, S.Min, Lee, J., Ahmad, T., Lee, M., Yang, H.-S., and Shin, H. (2019). Oxidative Epigallocatechin Gallate Coating on Polymeric Substrates for Bone Tissue Regeneration.Macromol Bioscie1800392.
Sheikhansari, G., Soltani-Zangbar, M.Sadegh, Pourmoghadam, Z., Kamrani, A., Azizi, R., Aghebati-Maleki, L., Danaii, S., Koushaeian, L., Hojat-Farsangi, M., and Yousefi, M. (2019). Oxidative stress, inflammatory settings, and microRNA regulation in the recurrent implantation failure patients with metabolic syndrome.Am J Reprod Immunole13170.
Klontzas, M.E., Reakasame, S., Silva, R., Morais, J.C.F., Vernardis, S., MacFarlane, R.J., Heliotis, M., Tsiridis, E., Panoskaltsis, N., Boccaccini, A.R., et al. (2019). Oxidized alginate hydrogels with the GHK peptide enhance cord blood mesenchymal stem cell osteogenesis: a paradigm for metabolomics-based evaluation of biomaterial design.Acta Biomater.
Papas, K.K., De Leon, H., Suszynski, T.M., and Johnson, R.C. (2019). Oxygenation strategies for encapsulated islet and beta cell transplants.Adv Drug Deliv Rev.